| Endothelial deletion of SHP2 suppresses tumor angiogenesis and promotes vascular normalization Z Xu, C Guo, Q Ye, Y Shi, Y Sun, J Zhang, J Huang, Y Huang, C Zeng, ... Nature communications 12 (1), 6310, 2021 | 76 | 2021 |
| PDLIM5 inhibits STUB1-mediated degradation of SMAD3 and promotes the migration and invasion of lung cancer cells Y Shi, X Wang, Z Xu, Y He, C Guo, L He, C Huan, C Cai, J Huang, ... Journal of Biological Chemistry 295 (40), 13798-13811, 2020 | 50 | 2020 |
| TKI resistant-based prognostic immune related gene signature in LUAD, in which FSCN1 contributes to tumor progression Y Shi, Y Xu, Z Xu, H Wang, J Zhang, Y Wu, B Tang, S Zheng, K Wang Cancer Letters 532, 215583, 2022 | 31 | 2022 |
| Endothelial scaffolding protein ENH (enigma homolog protein) promotes PHLPP2 (pleckstrin homology domain and leucine-rich repeat protein phosphatase 2)-mediated … J Huang, C Cai, T Zheng, X Wu, D Wang, K Zhang, B Xu, R Yan, H Gong, ... Arteriosclerosis, thrombosis, and vascular biology 40 (7), 1705-1721, 2020 | 29 | 2020 |
| Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy S Xu, C Wang, L Yang, J Wu, M Li, P Xiao, Z Xu, Y Xu, K Wang Frontiers in Immunology 14, 1199631, 2023 | 24 | 2023 |
| CRISPR/Cas-based CAR-T cells: production and application P Song, Q Zhang, Z Xu, Y Shi, R Jing, D Luo Biomarker Research 12 (1), 54, 2024 | 10 | 2024 |
| MARCH1 as a novel immune-related prognostic biomarker that shapes an inflamed tumor microenvironment in lung adenocarcinoma Z Xu, J Liu, Z Liu, H Zhang Frontiers in Oncology 12, 1008753, 2022 | 10 | 2022 |
| Circulating insulin-like growth factor-1 and risk of lung diseases: A Mendelian randomization analysis S Jiang, Z Xu, Y Shi, S Liang, X Jiang, M Xiao, K Wang, L Ding Frontiers in Endocrinology 14, 1126397, 2023 | 9 | 2023 |
| Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy M Xiao, Y Shi, S Jiang, M Cao, W Chen, Y Xu, Z Xu, K Wang Frontiers in Oncology 12, 1039378, 2022 | 6 | 2022 |
| Shp2 in myocytes is essential for cardiovascular and neointima development H Gong, J Ni, Z Xu, J Huang, J Zhang, Y Huang, C Zeng, X Zhang, ... Journal of Molecular and Cellular Cardiology 137, 71-81, 2019 | 6 | 2019 |
| HDKV: supporting efficient high‐dimensional similarity search in key‐value stores W Zhou, J Han, Z Zhang, J Dai, Z Xu Concurrency and Computation: Practice and Experience 25 (12), 1675-1698, 2013 | 6 | 2013 |
| PDZ and LIM domain-encoding genes: their role in cancer development X Jiang, Z Xu, S Jiang, H Wang, M Xiao, Y Shi, K Wang Cancers 15 (20), 5042, 2023 | 4 | 2023 |
| Cinchonine exerts anti-tumor and immunotherapy sensitizing effects in lung cancer by impairing autophagic-lysosomal degradation H Wang, Y Shi, D Ma, M Cao, Y Sun, X Jiang, Z Xu, Y Wang, Y Yang, ... Biomedicine & Pharmacotherapy 164, 114980, 2023 | 4 | 2023 |
| Identification of m7G-Related miRNA Signatures Associated with Prognosis, Oxidative Stress, and Immune Landscape in Lung Adenocarcinoma S Jiang, M Xiao, Y Shi, Y Wang, Z Xu, K Wang Biomedicines 11 (6), 1569, 2023 | 4 | 2023 |
| An efficient graph data processing system for large‐scale social network service applications W Zhou, J Han, Y Gao, Z Xu Concurrency and Computation: Practice and Experience 28 (3), 729-747, 2016 | 4 | 2016 |
| A Novel Clustering Algorithm on Large-Scale Graph Data H Zhang, W Zhou, X Wan, G Fu, Z Xu, J Han 2014 International Conference on Cloud Computing and Big Data, 47-54, 2014 | 2 | 2014 |
| VDMS: A Vector Data Management System for GIS Applications X Liu, S Zhang, J He, J Han, C Han, Z Xu 2008 International Conference on Networking, Architecture, and Storage, 278-284, 2008 | 2 | 2008 |
| Novel SERCA2 inhibitor Diphyllin displays anti-tumor effect in non-small cell lung cancer by promoting endoplasmic reticulum stress and mitochondrial dysfunction Z Xu, Y Shi, L Zhu, J Luo, Q Hu, S Jiang, M Xiao, X Jiang, H Wang, Y Xu, ... Cancer Letters, 217075, 2024 | 1 | 2024 |
| Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinoma X Mao, S Xu, H Wang, P Xiao, S Li, J Wu, J Sun, C Jin, M Shen, Y Shi, ... Cancer Cell International 24 (1), 173, 2024 | 1 | 2024 |
| GAB1 is upregulated to promote anaplastic thyroid cancer cell migration through AKT-MDR1 P Song, H Xu, Y He, J Sun, Z Xu, P Huang, M Ge, X Zhang, Y Ke, ... Biochemical and Biophysical Research Communications 607, 36-43, 2022 | 1 | 2022 |
